# Chemed Corp: Form 10-Q for the period ended Sep 30, 2012

- Company: [Chemed Corp](/companies/che.md) (CIK 19584)
- Form: 10-Q
- Filed: 2012-11-02
- Accepted by EDGAR: Nov 2, 2012, 13:31 ET
- Period: 2012-09-30
- Accession: 0001157523-12-005686
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/19584/000115752312005686/a50459158.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/19584/000115752312005686/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-07-01 to 2012-09-30 | $354.4m | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2012-01-01 to 2012-09-30 | $1.06bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2012-07-01 to 2012-09-30 | $256.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2012-01-01 to 2012-09-30 | $771.4m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months, 2012-07-01 to 2012-09-30 | $53.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2012-01-01 to 2012-09-30 | $155.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2012-07-01 to 2012-09-30 | $36.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2012-01-01 to 2012-09-30 | $110.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2012-07-01 to 2012-09-30 | $3.7m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2012-01-01 to 2012-09-30 | $11.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2012-07-01 to 2012-09-30 | $13.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2012-01-01 to 2012-09-30 | $39.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-07-01 to 2012-09-30 | $20.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2012-01-01 to 2012-09-30 | $62.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-07-01 to 2012-09-30 | $1.07 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2012-01-01 to 2012-09-30 | $3.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-07-01 to 2012-09-30 | $1.10 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2012-01-01 to 2012-09-30 | $3.30 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-07-01 to 2012-09-30 | 19,404,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2012-01-01 to 2012-09-30 | 19,382,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2012-01-01 to 2012-09-30 | $77.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2012-01-01 to 2012-09-30 | $26.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2012-01-01 to 2012-09-30 | $9.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2012-09-30 | $69.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-09-30 | $205.1m | us-gaap:AssetsCurrent |
| Total assets | at 2012-09-30 | $864.8m | us-gaap:Assets |
| Current liabilities | at 2012-09-30 | $147.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-09-30 | $390.2m | us-gaap:Liabilities |
| Long-term debt | at 2012-09-30 | $172.8m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2012-09-30 | $474.6m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2012-09-30 | 19,288,868 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/19584/000115752312005686/a50459158.htm

Filed Nov 2, 2012.
Source: SEC EDGAR, the filing index for accession 0001157523-12-005686. Last ingested by Listed: Nov 14, 2026, 12:29 ET. No prices; not investment advice.
